Atracurium besylate

Generic Name
Atracurium besylate
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C65H82N2O18S2
CAS Number
64228-81-5
Unique Ingredient Identifier
40AX66P76P
Background

A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.

Indication

For use, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Associated Conditions
-
Associated Therapies
Neuromuscular blocking therapy, Facilitation of small bowel intubation therapy

Effect of Atracurium and Rocuronium on the State and Response Entropy During Isoflurane Anesthesia

First Posted Date
2021-10-28
Last Posted Date
2021-10-28
Lead Sponsor
Ain Shams University
Target Recruit Count
40
Registration Number
NCT05097508
Locations
🇪🇬

Ain shams university, Cairo, Egypt

Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer Surgery

First Posted Date
2016-12-29
Last Posted Date
2023-12-21
Lead Sponsor
Tata Memorial Centre
Registration Number
NCT03005860
Locations
🇮🇳

Tata Memorial Centre, Mumbai, Maharashtra, India

© Copyright 2024. All Rights Reserved by MedPath